𝗧𝗵𝗲 𝗪𝗼𝗿𝗹𝗱 𝗠𝗲𝗹𝗮𝗻𝗼𝗺𝗮 𝗗𝗮𝘆 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 continues with a series of expert-led sessions and presentations, featuring leading clinicians and researchers who highlight emerging therapies, share real-world clinical insights, and explore strategies to advance early detection and improve outcomes in melanoma care worldwide. 𝗝𝗮𝗺𝗲𝘀 𝗦𝗺𝗶𝘁𝗵𝘆(@jsmithymd) discussed emerging cell therapy platforms for advanced melanoma, highlighting innovative adoptive cell therapies and next-generation immune-based strategies that are expanding treatment possibilities for patients with refractory disease. 𝗭𝘂𝗹𝗳𝗶𝗾𝘂𝗲𝗿 𝗢𝘁𝘁𝘆 reviewed current approaches to first-line therapy of metastatic melanoma, focusing on treatment selection, immunotherapy combinations, and factors guiding personalized management in clinical practice. 𝗔𝘅𝗲𝗹 𝗛𝗮𝘂𝘀𝗰𝗵𝗶𝗹𝗱 shared perspectives on how melanoma is treated across Europe, outlining regional practices, evolving therapeutic standards, and the integration of novel systemic therapies into routine care. 𝗭𝗮𝗵𝗿𝗮 𝗠𝗼𝗵𝗮𝗺𝗲𝗱 𝗔𝗵𝗺𝗲𝗱 explored the challenges encountered when clinical guidelines meet real-world practice, emphasizing practical decision-making, resource considerations, and adapting evidence-based recommendations to diverse patient settings. More insights continue to emerge as the OncoDaily Global Symposium unfolds 🌍 🔴 Live sessions available here: youtube.com/live/7TDHWCyn724… xitter.cf/i/broadcasts/1nxnRYQeA… #OncoDaily #Cancer #Oncology